DrugsControl Media Services

News Detail

US FDA guidance on formulation development to bolster opportunities for Indian companies (04-06-2024)

Bengaluru, 4 June 2024: Indian pharma’s global presence in generic medicine exports among others like biosimilars will indicate a strategic shift towards further expansion in the international markets particularly the US. To this end, the guidance from the US FDA on formula......
View Details

Source : Pharmabiz
global presence generic medicine biosimilars guidance India Ratings and Research US FDA pharma exports ANDAs Bal Pharma formulation development

Related News